FutureChem Co.Ltd Cash Flow Conversion Efficiency

Latest as of March 2026: 0.000x

FutureChem Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, FutureChem Co.Ltd (220100) has a cash flow conversion efficiency ratio of 0.000x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩13.90 Million ≈ $9.42K USD) by net assets (₩52.79 Billion ≈ $35.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of FutureChem Co.Ltd (2016–2025)

Cash flow conversion efficiency of FutureChem Co.Ltd from 2016 to 2025. This chart illustrates how FutureChem Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View FutureChem Co.Ltd share price for real-time trading data and today's change.

FutureChem Co.Ltd Cash Flow Conversion Ratio Explained

FutureChem Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

FutureChem Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of FutureChem Co.Ltd ranked by their cash flow conversion efficiency. Also see FutureChem Co.Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Kervan Gıda Sanayi Ve Ticaret As
IS:KRVGD
-0.001x
SINGULAR PEOPLE S EO-1
F:H0U
N/A
SHANGHAI FUDAN H YC-,10
F:FDY
N/A
Afyren SAS
PA:ALAFY
-0.044x
Taiwan Takisawa Technology Co Ltd
TWO:6609
-0.022x
Suzhou Shijing Environmental Technology Co.Ltd.
SHE:301030
N/A
DIOSTECH Co.Ltd
KQ:196450
-0.140x
Galleon Gold Corp
V:GGO
-0.044x

Annual Cash Flow Conversion Efficiency for FutureChem Co.Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of FutureChem Co.Ltd from 2016 to 2025. Review FutureChem Co.Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩54.83 Billion
≈ $37.16 Million
₩-2.43 Billion
≈ $-1.64 Million
-0.044x +24.98%
2024-12-31 ₩54.38 Billion
≈ $36.85 Million
₩-3.21 Billion
≈ $-2.17 Million
-0.059x -1.38%
2023-12-31 ₩63.91 Billion
≈ $43.31 Million
₩-3.72 Billion
≈ $-2.52 Million
-0.058x +46.36%
2022-12-31 ₩70.14 Billion
≈ $47.53 Million
₩-7.61 Billion
≈ $-5.16 Million
-0.109x -94.08%
2021-12-31 ₩52.72 Billion
≈ $35.72 Million
₩-2.95 Billion
≈ $-2.00 Million
-0.056x -6.51%
2020-12-31 ₩43.37 Billion
≈ $29.39 Million
₩-2.28 Billion
≈ $-1.54 Million
-0.052x +78.37%
2019-12-31 ₩11.16 Billion
≈ $7.57 Million
₩-2.71 Billion
≈ $-1.84 Million
-0.243x -19.64%
2018-12-31 ₩16.46 Billion
≈ $11.15 Million
₩-3.34 Billion
≈ $-2.26 Million
-0.203x -94.51%
2017-12-31 ₩27.20 Billion
≈ $18.43 Million
₩-2.84 Billion
≈ $-1.92 Million
-0.104x -49.37%
2016-12-31 ₩31.53 Billion
≈ $21.37 Million
₩-2.20 Billion
≈ $-1.49 Million
-0.070x --

About FutureChem Co.Ltd

KQ:220100 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$100.14 Million
₩147.76 Billion KRW
Market Cap Rank
#18994 Global
#903 in Korea
Share Price
₩6590.00
Change (1 day)
-8.85%
52-Week Range
₩5980.00 - ₩34200.00
All Time High
₩34200.00
About

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products i… Read more